Raymond James Financial Services Advisors, Inc. - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$363,449
-7.5%
46,596
-2.4%
0.00%0.0%
Q2 2023$393,106
+19.5%
47,765
+5.2%
0.00%0.0%
Q1 2023$329,041
-8.1%
45,385
+12.5%
0.00%0.0%
Q4 2022$357,931
-27.4%
40,353
+0.1%
0.00%0.0%
Q3 2022$493,000
+12.6%
40,293
+8.8%
0.00%0.0%
Q2 2022$438,000
-37.7%
37,028
+0.2%
0.00%0.0%
Q1 2022$703,000
-34.5%
36,966
-8.6%
0.00%
-50.0%
Q4 2021$1,074,000
-50.6%
40,459
-23.5%
0.00%
-50.0%
Q3 2021$2,174,000
-20.8%
52,912
+9.2%
0.00%
-33.3%
Q2 2021$2,744,000
+36.1%
48,442
+0.9%
0.01%
+20.0%
Q1 2021$2,016,000
-52.7%
47,998
-21.0%
0.01%
-54.5%
Q4 2020$4,259,000
+215.5%
60,748
+26.2%
0.01%
+175.0%
Q3 2020$1,350,000
-2.1%
48,125
+3.2%
0.00%0.0%
Q2 2020$1,379,000
+136.5%
46,627
+58.6%
0.00%
+33.3%
Q1 2020$583,000
-13.8%
29,403
+28.8%
0.00%
+50.0%
Q4 2019$676,000
+63.3%
22,823
+25.3%
0.00%0.0%
Q3 2019$414,000
-10.2%
18,221
-2.2%
0.00%0.0%
Q2 2019$461,000
-17.8%
18,626
-18.8%
0.00%0.0%
Q1 2019$561,000
+10.9%
22,932
+3.1%
0.00%
-33.3%
Q4 2018$506,000
-44.9%
22,238
-22.9%
0.00%
-25.0%
Q3 2018$918,000
+16.1%
28,837
+30.7%
0.00%0.0%
Q2 2018$791,000
+107.1%
22,066
+91.7%
0.00%
+100.0%
Q1 2018$382,000
+24.8%
11,510
+15.6%
0.00%0.0%
Q4 2017$306,0009,9590.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders